JPS5058211A - - Google Patents

Info

Publication number
JPS5058211A
JPS5058211A JP49093481A JP9348174A JPS5058211A JP S5058211 A JPS5058211 A JP S5058211A JP 49093481 A JP49093481 A JP 49093481A JP 9348174 A JP9348174 A JP 9348174A JP S5058211 A JPS5058211 A JP S5058211A
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP49093481A
Other languages
Japanese (ja)
Other versions
JPS557407B2 (https=
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPS5058211A publication Critical patent/JPS5058211A/ja
Publication of JPS557407B2 publication Critical patent/JPS557407B2/ja
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP9348174A 1973-08-17 1974-08-16 Expired JPS557407B2 (https=)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US38930273A 1973-08-17 1973-08-17

Publications (2)

Publication Number Publication Date
JPS5058211A true JPS5058211A (https=) 1975-05-21
JPS557407B2 JPS557407B2 (https=) 1980-02-25

Family

ID=23537694

Family Applications (1)

Application Number Title Priority Date Filing Date
JP9348174A Expired JPS557407B2 (https=) 1973-08-17 1974-08-16

Country Status (17)

Country Link
US (1) US4158055A (https=)
JP (1) JPS557407B2 (https=)
BE (1) BE818929A (https=)
CH (1) CH601353A5 (https=)
CY (1) CY946A (https=)
DE (1) DE2437847C3 (https=)
FR (1) FR2240738B1 (https=)
GB (1) GB1442925A (https=)
HK (1) HK44778A (https=)
HU (1) HU172213B (https=)
IE (1) IE39738B1 (https=)
IL (1) IL45200A (https=)
KE (1) KE2820A (https=)
MY (1) MY7800234A (https=)
NL (1) NL184899C (https=)
PH (1) PH12415A (https=)
ZA (1) ZA744259B (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62281817A (ja) * 1975-05-27 1987-12-07 シンテツクス,(ユ−,エス,エイ) インコ−ポレ−テツド 鼻用噴霧液

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10326899A1 (de) * 2003-06-14 2004-12-30 Beiersdorf Ag Kosmetische Zubereitungen mit stabilisierten Konservierungsmitteln
JP2007504123A (ja) * 2003-08-29 2007-03-01 ランバクシー ラボラトリーズ リミテッド Iv型ホスホジエステラーゼの阻害剤
WO2005028495A1 (en) * 2003-09-24 2005-03-31 Glaxo Group Limited Anti-inflammatory glucocorticoids
EP1694655A2 (en) * 2003-11-26 2006-08-30 Ranbaxy Laboratories Limited Phosphodiesterase inhibitors
WO2007031838A1 (en) 2005-09-16 2007-03-22 Ranbaxy Laboratories Limited Substituted pyrazolo [3,4-b] pyridines as phosphodiesterase inhibitors
WO2007045980A1 (en) * 2005-10-19 2007-04-26 Ranbaxy Laboratories Limited Compositions of phosphodiesterase type iv inhibitors
RU2008119323A (ru) 2005-10-19 2009-11-27 Рэнбакси Лабораториз Лимитед (In) Фармацевтические композиции мускаринового рецептора
EA200900472A1 (ru) * 2006-09-22 2009-10-30 Ранбакси Лабораторис Лимитед Ингибиторы фосфодиэстеразы iv типа
US20100029728A1 (en) * 2006-09-22 2010-02-04 Ranbaxy Laboratories Limited Phosphodiesterase inhibitors
EP1958947A1 (en) 2007-02-15 2008-08-20 Ranbaxy Laboratories Limited Inhibitors of phosphodiesterase type 4
WO2008111009A1 (en) * 2007-03-14 2008-09-18 Ranbaxy Laboratories Limited Pyrazolo [3, 4-b] pyridine derivatives as phosphodiesterase inhibitors
DK2124944T3 (da) 2007-03-14 2012-04-23 Ranbaxy Lab Ltd Pyrazolo[3,4-b]pyridinderivater som phosphodiesteraseinhibitorer
EP2111861A1 (en) 2008-04-21 2009-10-28 Ranbaxy Laboratories Limited Compositions of phosphodiesterase type IV inhibitors
US8900626B2 (en) 2011-06-20 2014-12-02 Senju Usa, Inc. Transdermal drug delivery system and method of using the same
CN113698448B (zh) * 2021-10-29 2022-02-22 山东谷雨春生物科技有限公司 一种安西奈德的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB894810A (en) * 1959-10-05 1962-04-26 American Cyanamid Co Aqueous pharmaceutical solutions containing anti-inflammatory steroids
US3048581A (en) * 1960-04-25 1962-08-07 Olin Mathieson Acetals and ketals of 16, 17-dihydroxy steroids
GB928150A (en) * 1961-02-08 1963-06-06 Upjohn Co Topical pharmaceutical compositions comprising steroids and flavonoids
US3053836A (en) * 1961-07-14 1962-09-11 Olin Mathieson Acetals and ketals of 16alpha, 17alpha-dihydroxyprogesterones
US3541602A (en) * 1968-07-29 1970-11-17 Squibb & Sons Inc Acetonides of 9-halogenated 3beta,11beta,10alpha,17alpha,21-pentahydroxypregnanes
GB1382614A (en) * 1972-01-10 1975-02-05 Squibb & Sons Inc Steroid compositions
US3867528A (en) * 1973-10-11 1975-02-18 American Cyanamid Co Steroidal topical cream base

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62281817A (ja) * 1975-05-27 1987-12-07 シンテツクス,(ユ−,エス,エイ) インコ−ポレ−テツド 鼻用噴霧液

Also Published As

Publication number Publication date
IE39738B1 (en) 1978-12-20
IE39738L (en) 1975-02-17
FR2240738A1 (https=) 1975-03-14
DE2437847B2 (de) 1980-06-19
NL184899B (nl) 1989-07-03
CH601353A5 (https=) 1978-07-14
MY7800234A (en) 1978-12-31
HU172213B (hu) 1978-07-28
JPS557407B2 (https=) 1980-02-25
DE2437847A1 (de) 1975-02-27
AU7073674A (en) 1976-01-08
CY946A (en) 1978-06-23
FR2240738B1 (https=) 1980-04-11
BE818929A (fr) 1975-02-17
GB1442925A (en) 1976-07-14
IL45200A (en) 1978-08-31
IL45200A0 (en) 1974-11-29
DE2437847C3 (de) 1981-03-12
US4158055A (en) 1979-06-12
NL184899C (nl) 1989-12-01
ZA744259B (en) 1975-06-25
PH12415A (en) 1979-02-07
NL7410613A (nl) 1975-02-19
HK44778A (en) 1978-08-18
KE2820A (en) 1978-03-10

Similar Documents

Publication Publication Date Title
AU476761B2 (https=)
AU465372B2 (https=)
AU474593B2 (https=)
AU474511B2 (https=)
AU474838B2 (https=)
AU465453B2 (https=)
AU471343B2 (https=)
JPS557407B2 (https=)
AU465434B2 (https=)
AU476714B2 (https=)
AR201229Q (https=)
AU476696B2 (https=)
AU472848B2 (https=)
AU466283B2 (https=)
AR199451A1 (https=)
AU477823B2 (https=)
AR200885A1 (https=)
AR200256A1 (https=)
AU471461B2 (https=)
AU476873B1 (https=)
AR196382A1 (https=)
AR197627A1 (https=)
AU477824B2 (https=)
CH559474A4 (https=)
AU479422A (https=)